<DOC>
	<DOCNO>NCT00669760</DOCNO>
	<brief_summary>Staphylococcus aureus one first pathogens infect airway cystic fibrosis ( CF ) patient , also highly prevalent microorganism ( &gt; 60 % CF patient ; European American CF registry ; ( 4,25 ) , often persist several year respiratory tract CF patient . The purpose study dissect infection S. aureus colonization . Therefore , follow non-interventional prospective , longitudinal multicenter study conduct develop follow hypothesis : CF patient high bacterial load likely infect S. aureus patient low bacterial load . Primary endpoint : bacterial load sputum culture Secondary endpoint : - nasal carriage - molecular analysis S. aureus ( Monoclonal/polyclonal ) - serum : S. aureus-specific antibody , S100A12 , IL-8 , TNF-alpha - sputum : S100A12 , IL-8 , myeloperoxidase - S. aureus therapy regimens - lung function test : FEV1 , deltaFVC , deltaMEF25 - BMI development Inclusion criterion : S. aureus culture 6 month within last year , child ( &gt; 6 year ) patient , able perform lung function test Exclusion criterion : P. aeruginosa and/or B. cepacia culture specimens 6 month within last year recruitment study period In addition microbiological investigation clinical laboratory test , actual clinical situation evaluate report study period . The result observational study use carefully plan clinical interventional study . Furthermore , result might possible characterize subpopulation patient , great risk S. aureus infection .</brief_summary>
	<brief_title>Dissection Staphylococcus Aureus Infection From Colonization Cystic Fibrosis Patients</brief_title>
	<detailed_description>Protocol synopsis Title : Dissection Staphylococcus aureus infection colonization cystic fibrosis patient . A non-interventional prospective , 2-year longitudinal multicenter study Study objective : The aim study dissect S. aureus infection colonization pathogen airway secretion CF patient 2 year period mean non-interventional , prospective , longitudinal multicenter study . The following hypothesis develop : CF patient high bacterial load likely infect S. aureus patient low bacterial load . Definition infection : - change volume , colour consistency sputum ( exacerbation ) - increase cough - malaise , fatigue lethargy - body temperature 38Â°C - new increase hemoptysis - anorexia weight loss - sinus pain tenderness - change sinus discharge - change chest sound - ten percent decrease pulmonary function previous record value ( FEV1 , MEF25 ) - radiographic change indicative pulmonary infection Primary endpoint : bacterial load sputum culture [ high ( &gt; /= 106CFU/ml ) ; low ( &lt; 106CFU/ml ) ] Secondary endpoint : - assessment nasal S. aureus carriage - serum sample : antibody titres S. aureus specific antigens ; S100A12 , IL-8 , TNF-alpha , CRP - molecular analysis S. aureus colonization/infection ( monoclonal heteroclonal ) - sputa analysis : activity S100A12 , IL-8 myeloperoxidase - antibiotic treatment regimen S. aureus - body mass index - lung function test : FEV1 , deltaFVC , deltaMEF25 Extensive microbiological investigation perform patient see regular visit outpatient clinic exacerbation occur . During study period 2 year , least 8 visit outpatient clinic record . The following clinical parameter document : - lung function - body mass index ( weight/height ) - antibiotic treatment Diagnosis : CF positive S. aureus culture 6 month within last year Localisation study : multicenter study Germany Number center : Seven centre agree already participate study . More center contact . Design : non-interventional prospective , longitudinal multicenter study Planned number patients/volunteers : 228 Inclusion criterion : positive S. aureus culture 6 month within last year ; child ( &gt; 6 year ) patient CF , able perform lung function test Exclusion criterion : Pseudomonas aeruginosa and/or Burkholderia cepacia colonization infection 6 month within last year recruitment ; patient colonize pathogen acquire within study period colonized/infected 6 month observation period</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<criteria>positive S. aureus culture 6 month within last year ; child ( &gt; 6 year ) patient CF , able perform lung function test Pseudomonas aeruginosa and/or Burkholderia cepacia colonization infection 6 month within last year recruitment ; patient colonize pathogen acquire within study period colonized/infected 6 month observation period</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>cystic fibrosis</keyword>
	<keyword>Staphylococcus aureus</keyword>
	<keyword>persistent colonization-infection</keyword>
	<keyword>clinical status</keyword>
	<keyword>lung function</keyword>
</DOC>